Siheung–(Newswire) December 29, 2020 – T&R Biofab (246710, CEO Wonsoo Yoon), a 3D bioprinting company, announced’MIXING DEVICE FOR CELL PRINTING COMPOSITION’. Obtained a US patent.
This patented technology is a new technology for a device that uniformly mixes the hydrogel, the main material of bio-ink, and cells without external power in the preparation stage for 3D bioprinting.
As the conventional mixing method, the method of using a static mixing device or mixing directly by human hand was mainly used, but the mixing process was inefficient and the cell viability was very low.
On the other hand, the device of T&R Biofab, which acquired the patent this time, can △dynamic mixing without a separate external power unit, while △complementing the shortcomings of the existing method by increasing the homogeneity of mixing hydrogels and cells. △ In addition, it is characterized by improved efficiency as it was developed in a one-stop structure in which materials are injected and mixed.
T&R Biofab expects to establish a uniform cell production process by using the technology and devices in various bioprinting fields. Accordingly, in the future, the company plans to apply it to the company’s 3D bioprinting process to expand the scope of its use by implementing and manufacturing artificial tissue structures and artificial organs, and will make more efforts to derive R&D results by strengthening technology in the field and creating technological synergy. .
Meanwhile, the company has already registered a patent for this technology and device in Korea, and has already applied for a patent in Europe following the US, and is currently undergoing a patent registration examination process. As a result, the company has secured 70 domestic and foreign registered patents.
Website: http://www.tnrbiofab.com
This news is a press release released by companies and organizations. Can be used for news reporting. Information Use